RecruitingNot Applicable

Identification of Biomarkers for Patients with Vascular Anomalies

United States1,000 participantsStarted 2015-04

Plain-language summary

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.

Who can participate

Age range1 Day

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient having labs drawn as standard of care will have blood drawn for the study if consented/ assented. * All patients who are undergoing a surgical procedure or sclerotherapy are currently consented for participation in the tissue bank. Exclusion Criteria: * N/A

What they're measuring

Correlation of Biomarkers with Differential Diagnosis

Timeframe: An Average of Every 2 Years

Correlation of Biomarkers with Disease Severity

Timeframe: An Average of Every 2 Years

Correlation of Biomarkers with Response to Therapies

Timeframe: An Average of Every 2 Years

Trial details

NCT IDNCT03001180

SponsorChildren's Hospital Medical Center, Cincinnati

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2050-12

Contact for this trial

Timothy LeCras, PhD

5138034862 hvmcresearch@cchmc.org

View on ClinicalTrials.gov More Vascular Anomaly trials